SLC11A2 and kidney cancer: Setting p < 0.001 as the threshold, the two GENT microarray data were intersected to obtain SLC11A2 mRNA with elevated transcript levels in blood, breast, colon, liver, lung, and ovary cancers and reduced transcript levels in kidney cancer.